Proceedings of the 2023 annual meeting of European Association for the Study of Diabetes: Advances in diabetes mellitus and other metabolic diseases / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 258-266, 2024.
Article
en Zh
| WPRIM
| ID: wpr-1028645
Biblioteca responsable:
WPRO
ABSTRACT
The 59th European Association for the Study of Diabetes(EASD) annual meeting was held in Hamburg, Germany from October 2nd to 6th, 2023. In the past decades, there have been significant advancements in the clinical management of diabetes. Novel anti-hyperglycemic medications, particularly those targeting the glucagon-like peptide-1 receptor and dual/multiple receptors, have garnered attention. These medications show great promise in glycemic control, weight reduction, metabolic improvements, and additional benefits. This article provided an overview of some of the key topics discussed at this EASD conference.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Endocrinology and Metabolism
Año:
2024
Tipo del documento:
Article